Alembic Pharmaceuticals Limited

NSEI:APLLTD Rapporto sulle azioni

Cap. di mercato: ₹234.9b

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Alembic Pharmaceuticals Dividendo

Dividendo criteri di controllo 4/6

Alembic Pharmaceuticals è una società che paga dividendi con un rendimento attuale pari a 1.03%, ben coperto dagli utili.

Informazioni chiave

0.9%

Rendimento del dividendo

35%

Rapporto di remunerazione

Rendimento medio del settore0.6%
Prossima data di pagamento dei dividendin/a
Data di stacco del dividendon/a
Dividendo per azione₹11.000
Utile per azione₹32.05
Previsione del rendimento del dividendo1.4%

Aggiornamenti recenti sui dividendi

Recent updates

Alembic Pharmaceuticals Limited's (NSE:APLLTD) Intrinsic Value Is Potentially 17% Below Its Share Price

Sep 25
Alembic Pharmaceuticals Limited's (NSE:APLLTD) Intrinsic Value Is Potentially 17% Below Its Share Price

Is Alembic Pharmaceuticals (NSE:APLLTD) Using Too Much Debt?

Sep 03
Is Alembic Pharmaceuticals (NSE:APLLTD) Using Too Much Debt?

Alembic Pharmaceuticals Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Aug 13
Alembic Pharmaceuticals Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Market Participants Recognise Alembic Pharmaceuticals Limited's (NSE:APLLTD) Earnings Pushing Shares 25% Higher

Jul 20
Market Participants Recognise Alembic Pharmaceuticals Limited's (NSE:APLLTD) Earnings Pushing Shares 25% Higher

Alembic Pharmaceuticals (NSE:APLLTD) Seems To Use Debt Rather Sparingly

Jun 03
Alembic Pharmaceuticals (NSE:APLLTD) Seems To Use Debt Rather Sparingly

Does This Valuation Of Alembic Pharmaceuticals Limited (NSE:APLLTD) Imply Investors Are Overpaying?

May 11
Does This Valuation Of Alembic Pharmaceuticals Limited (NSE:APLLTD) Imply Investors Are Overpaying?

Results: Alembic Pharmaceuticals Limited Exceeded Expectations And The Consensus Has Updated Its Estimates

Feb 08
Results: Alembic Pharmaceuticals Limited Exceeded Expectations And The Consensus Has Updated Its Estimates

Subdued Growth No Barrier To Alembic Pharmaceuticals Limited (NSE:APLLTD) With Shares Advancing 25%

Jan 21
Subdued Growth No Barrier To Alembic Pharmaceuticals Limited (NSE:APLLTD) With Shares Advancing 25%

Is Alembic Pharmaceuticals (NSE:APLLTD) A Risky Investment?

Jan 05
Is Alembic Pharmaceuticals (NSE:APLLTD) A Risky Investment?

Here's Why Alembic Pharmaceuticals (NSE:APLLTD) Can Manage Its Debt Responsibly

Sep 27
Here's Why Alembic Pharmaceuticals (NSE:APLLTD) Can Manage Its Debt Responsibly

Alembic Pharmaceuticals (NSE:APLLTD) Seems To Use Debt Quite Sensibly

Jun 09
Alembic Pharmaceuticals (NSE:APLLTD) Seems To Use Debt Quite Sensibly

A Look At The Fair Value Of Alembic Pharmaceuticals Limited (NSE:APLLTD)

Apr 13
A Look At The Fair Value Of Alembic Pharmaceuticals Limited (NSE:APLLTD)

Is Alembic Pharmaceuticals (NSE:APLLTD) A Risky Investment?

Feb 22
Is Alembic Pharmaceuticals (NSE:APLLTD) A Risky Investment?

Alembic Pharmaceuticals Limited (NSE:APLLTD) Shares Could Be 21% Below Their Intrinsic Value Estimate

Jan 04
Alembic Pharmaceuticals Limited (NSE:APLLTD) Shares Could Be 21% Below Their Intrinsic Value Estimate

We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Alembic Pharmaceuticals Limited's (NSE:APLLTD) CEO For Now

Nov 05
We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Alembic Pharmaceuticals Limited's (NSE:APLLTD) CEO For Now

Here's Why Alembic Pharmaceuticals (NSE:APLLTD) Has A Meaningful Debt Burden

Aug 10
Here's Why Alembic Pharmaceuticals (NSE:APLLTD) Has A Meaningful Debt Burden

Estimating The Intrinsic Value Of Alembic Pharmaceuticals Limited (NSE:APLLTD)

Jul 20
Estimating The Intrinsic Value Of Alembic Pharmaceuticals Limited (NSE:APLLTD)

We Think Alembic Pharmaceuticals (NSE:APLLTD) Is Taking Some Risk With Its Debt

May 05
We Think Alembic Pharmaceuticals (NSE:APLLTD) Is Taking Some Risk With Its Debt

Stabilità e crescita dei pagamenti

Recupero dei dati sui dividendi

Dividendo stabile: I pagamenti dei dividendi di APLLTD sono stati volatili negli ultimi 10 anni.

Dividendo in crescita: I pagamenti dei dividendi di APLLTD sono aumentati negli ultimi 10 anni.


Rendimento dei dividendi rispetto al mercato

Alembic Pharmaceuticals Rendimento dei dividendi rispetto al mercato
Come si colloca il rendimento da dividendo di APLLTD rispetto al mercato?
SegmentoRendimento dei dividendi
Azienda (APLLTD)0.9%
Fondo del 25% del mercato (IN)0.2%
Top 25% del mercato (IN)1.0%
Media del settore (Pharmaceuticals)0.6%
Analista previsionale (APLLTD) (fino a 3 anni)1.4%

Dividendo notevole: Il dividendo di APLLTD ( 1.03% ) è più alto rispetto al 25% inferiore dei pagatori di dividendi nel mercato Indian ( 0.25% ).

Dividendo elevato: Il dividendo di APLLTD ( 1.03% ) è basso rispetto al 25% dei maggiori pagatori di dividendi nel mercato Indian ( 1.08%.


Distribuzione degli utili agli azionisti

Copertura degli utili: Grazie al suo payout ratio ( 35.1% ) ragionevolmente basso, i pagamenti dei dividendi di APLLTD sono ben coperti dagli utili.


Pagamenti in contanti agli azionisti

Copertura del flusso di cassa: Grazie al suo cash payout ratio ( 45.5% ) ragionevolmente basso, i pagamenti dei dividendi di APLLTD sono ben coperti dai flussi di cassa.


Scoprire le società che pagano dividendi forti